Bispecific Antibodies in Glioblastoma: Mechanistic Advances, Delivery Innovations, and Translational Challenges in Overcoming Immune Escape
International Journal of Medical Sciences · 01.10.2025 · 22 (16) · 4250-4277
DOI: 10.7150/ijms.121829 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Medical Sciences, erschienen am 01.10.2025. Verfasst von He-Lu Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Shandong Second Medical University, Weifang, China. Hauptthemen laut MEDLINE: Glioblastoma, Antibodies, Bispecific, Brain Neoplasms, Tumor Escape. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
- Neurosurgery Department of Yantai Yuhuangding Hospital, Yantai, China.
Zitieren
APA
Wang, H. L., Chi, N., & Zhang, H. T. (2025). Bispecific Antibodies in Glioblastoma: Mechanistic Advances, Delivery Innovations, and Translational Challenges in Overcoming Immune Escape. International Journal of Medical Sciences, 22(16), 4250-4277. https://doi.org/10.7150/ijms.121829
Vancouver
Wang HL, Chi N, Zhang HT. Bispecific Antibodies in Glioblastoma: Mechanistic Advances, Delivery Innovations, and Translational Challenges in Overcoming Immune Escape. International Journal of Medical Sciences. 2025;22(16):4250-4277. doi:10.7150/ijms.121829
BibTeX
@article{Wang2025,
author = {Wang, He-Lu and Chi, Nan and Zhang, Hong-Tao},
title = {Bispecific Antibodies in Glioblastoma: Mechanistic Advances, Delivery Innovations, and Translational Challenges in Overcoming Immune Escape},
journal = {International Journal of Medical Sciences},
year = {2025},
volume = {22},
number = {16},
pages = {4250--4277},
doi = {10.7150/ijms.121829}
}
EUVIMED